NEW YORK, July 9 - David Botstein , the new director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University , will be presented with the 2003 Genetics prize Thursday at the XIX International Congress of Genetics in Melbourne, Australia. The prize, awarded by the Peter Gruber Foundation , includes a medal and a check for $150,000.
Virgil Elings , David O'Bryan , and Peter Schwartz have joined the scientific advisory board of BioForce Nanosciences , the Ames, Iowa, company said July 8. BioForce makes nano-array systems in which atomic force microscopy is used for detection of molecules.
Elings is a former physics professor at the University of California, Santa Barbara , where he developed scanning probe microscopy for imaging of individual atoms, and founded Digital Instruments to commercialize this technology.
O'Bryan is the managing director of Hibernia Consulting partners, which does operational consulting for life sciences companies. Prior to this, O'Bryan was the senior vice president at SmithKline Beecham Clinical Laboratories.
Schwartz is an assistant professor of physics at California Polytechnic State University , San Luis Obispo. He invented "High Force Nanografting," a nanolithography technology.
Shai Erlich , the senior director of portfolio management at Quark Biotech , has moved from the company's Israel facility to its newly opened facility in Fremont, Calif., where he will head up operations, the company said July 8.
The new 22,000 square-foot facility is to house the company's three business units, including microarray technology, product development, and business development. The company plans to add staff in the clinical development area.
Quark Biotech is privately-held and is based in Cleveland, Ohio.
Juan Santiago and Evan Williams have joined the scientific advisory board of Target Discovery , a Palo Alto, Calif.-based drug discovery company, the company said July 8.
Santiago is director of Stanford University s microfluidics laboratory, and holds a faculty position in the mechanical engineering department. He studies the fluid dynamics of micro-scale systems and the design and manufacture of these systems.
Williams is a researcher at Lawrence Berkeley National Laboratory and is also on the chemistry and biophysics faculty at the University of California, Berkeley . He researches the use of novel mass spectrometry instruments, including protein identification methods.
Michael Spicer has been named chief financial officer at Orchid Biosciences , and current CFO Andrew Savadelis is leaving the company.
Spicer has been vice president of finance at Orchid since December 2001, when the company acquired Lifecodes , where he was vice president, CFO, treasurer, and secretary. Prior to joining Lifecodes, Spicer worked in finance and accounting at a number of companies, including White River , The Chinet Company , Kraft General Foods , and Deloitte & Touche . This change in management comes a little more than one month after Paul Kelly took the helm as CEO and laid off employees in restructuring the company's personalized medicine business unit.
William Heydorn has been appointed vice president of pre-clinical development at Lexicon Genetics, the company said July 7.
Heydorn comes to the company, based in The Woodlands, Texas, from a position as director of medical affairs and scientific communications at Forest Laboratories . Prior to that, he was director of pharmaceutical operations at Synaptic Pharmaceutical , and has served in positions at Merrell Dow/Marion Merrell Dow , the US Food and Drug Administration, and the National Institute of Mental Health .
Lorne Babiuk , of the University of Saskatchewan' s Vaccine and Infectious Disease Organization , has received the industry leadership award from the Animal Health Institute, the Western Producer reported July 7.
Babuik recently spearheaded a $CA27 million ($19.7 million) infectious disease genomics project -- a collaboration between the Vaccine and Infectious Diseases Organization, the University of British Columbia , and two corporate partners, the paper reported.
Skip Shimer has been appointed chief executive officer of Cellicon Biotechnologies , the Boston-based company said July 3.
Shimer comes to Cellicon from Cubist Pharmaceuticals , where he was vice president of research. Before joining Cubist, Shimer was senior director of pathogen genomics at Genome Therapeutics .
Douglas Darr , Patrick Morand , and Reed McManigle have all joined the Pittsburgh Life Sciences Greenhouse , the organization said July 2.
Darr, who will be vice president and Chief Scientific Officer of the biotech incubator, comes to Pittsburgh from the North Carolina Biotechnology Center , where he was vice president of the business and technology development program for over eight years. He was also a consultant to life sciences companies and organizations in the Raleigh-Durham area. Prior to this, Darr was involved in research studies at Duke University Medical Center .
Morand, who will be the PLSG's executive-in-residence, was vice president of commercial operations for genomic-and-proteomic research firm Genesis Therapeutics . Prior to this, he was executive vice president of Sequitor Medical Technologies in Chicago, and before this, he was president and CEO of LifeSource , from 1992-1996. From 1970 to 1992, Morand worked for the American Red Cross , and was CEO of the Baltimore and St. Paul divisions.
McManigle joins PSLG as director of incubator and entrepreneurial education from the University of Pittsburgh , where he has served as technology licensing manager for the past ten years.